שווי כולל של החברה: Notable Labs, Ltd. (NTBL)

Notable Labs, Ltd. (NTBL) creates personalized therapy regimens using a functional analysis system to select optimal medications based on the reaction of a patient's live cells. Physicians value the project for its innovative AI forecasting, while it maintains its status as a promising venture startup. The market capitalization trend, which reached , highlights R&D complexities, stringent FDA oversight, and the high entry barriers of the PPMP platform.

Enterprise Value aggregates market capitalization and net debt, determining the total cost of acquiring control over assets while accounting for all liabilities. For Notable Labs, Ltd. (NTBL), which is currently developing IT platforms and consuming capital without a stable cash flow, the current enterprise value reflects the cost of investment risk and the expenses required to maintain business operations.